These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 458195)

  • 1. Pulmonary and systemic defenses against challenge with Staphylococcus aureus in mice with pneumonia due to influenza A virus.
    Jakab GJ; Warr GA; Knight ME
    J Infect Dis; 1979 Jul; 140(1):105-8. PubMed ID: 458195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung defenses against viral and bacterial challenges during immunosuppression with cyclophosphamide in mice.
    Jakab GJ; Warr GA
    Am Rev Respir Dis; 1981 May; 123(5):524-8. PubMed ID: 6263138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin-induced suppression of lung host defenses.
    Nelson S; Chidiac C; Bagby G; Summer WR
    J Med; 1990; 21(1-2):85-103. PubMed ID: 2120377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminophylline-induced suppression of pulmonary antibacterial defenses.
    Nelson S; Summer WR; Jakab GJ
    Am Rev Respir Dis; 1985 Jun; 131(6):923-7. PubMed ID: 3890643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcal clearance and pulmonary macrophage function during influenza infection.
    Nugent KM; Pesanti EL
    Infect Immun; 1982 Dec; 38(3):1256-62. PubMed ID: 7152668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes.
    Bettina A; Zhang Z; Michels K; Cagnina RE; Vincent IS; Burdick MD; Kadl A; Mehrad B
    J Immunol; 2016 Jun; 196(12):5047-55. PubMed ID: 27183631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia.
    Jakab GJ
    Am Rev Respir Dis; 1982 Nov; 126(5):778-82. PubMed ID: 7149441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effect of a cigarette smoke component, acrolein, on pulmonary antibacterial defenses and on viral-bacterial interactions in the lung.
    Jakab GJ
    Am Rev Respir Dis; 1977 Jan; 115(1):33-8. PubMed ID: 835891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia.
    Robinson KM; Lee B; Scheller EV; Mandalapu S; Enelow RI; Kolls JK; Alcorn JF
    Respir Res; 2015 Feb; 16(1):10. PubMed ID: 25651926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung.
    Nelson S; Summer WR; Terry PB; Warr GA; Jakab GJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1207-12. PubMed ID: 3314615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of prior influenza infection on alveolar macrophage phagocytosis of Staphylococcus aureus and Escherichia coli: involvement of interferon-gamma production.
    Hang do TT; Choi EJ; Song JY; Kim SE; Kwak J; Shin YK
    Microbiol Immunol; 2011 Nov; 55(11):751-9. PubMed ID: 21895747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous carrageenan on immune responses and on the reticulonendothelial system.
    Turner EV; Higginbotham RD
    J Reticuloendothel Soc; 1979 Dec; 26(6):763-73. PubMed ID: 392091
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary antibacterial defenses during mild and severe influenza virus infection.
    Nickerson CL; Jakab GJ
    Infect Immun; 1990 Sep; 58(9):2809-14. PubMed ID: 2143751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune enhancement of pulmonary bactericidal activity in murine virus pneumonia.
    Jakab GJ; Green GM
    J Clin Invest; 1973 Nov; 52(11):2878-84. PubMed ID: 4356001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza virus infection and bacterial clearance in young adult and aged mice.
    Wyde PR; Six HR; Ambrose MW; Throop BJ
    J Gerontol; 1989 Sep; 44(5):B118-24. PubMed ID: 2475539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Staphylococcus protease in the development of influenza pneumonia.
    Tashiro M; Ciborowski P; Klenk HD; Pulverer G; Rott R
    Nature; 1987 Feb 5-11; 325(6104):536-7. PubMed ID: 3543690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between granulocytes and antibodies in the enhancement of lung defenses against Staphylococcus aureus after intranasal immunization of mice with live-attenuated bacteria.
    García VE; Iglesias MF; Cerquetti MC; Gómez MI; Sordelli DO
    FEMS Immunol Med Microbiol; 1994 Jun; 9(1):55-63. PubMed ID: 7920464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin pretreatment improves bacterial clearance and decreases mortality in mice challenged with Staphylococcus aureus.
    Murphey ED; Fang G; Sherwood ER
    Shock; 2008 Apr; 29(4):512-8. PubMed ID: 17724430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolitis induced by influenza virus.
    Jakab GJ; Astry CL; Warr GA
    Am Rev Respir Dis; 1983 Oct; 128(4):730-9. PubMed ID: 6625351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of influenza infection on the phagocytic and bactericidal activities of pulmonary macrophages.
    Nugent KM; Pesanti EL
    Infect Immun; 1979 Nov; 26(2):651-7. PubMed ID: 546791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.